Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A Rat Model of Alzheimer's Disease Based on Abeta42 and Pro-oxidative Substances Exhibits Cognitive Deficit and Alterations in Glutamatergic and Cholinergic Neurotransmitter Systems

T. Petrasek, M. Skurlova, K. Maleninska, I. Vojtechova, Z. Kristofikova, H. Matuskova, J. Sirova, K. Vales, D. Ripova, A. Stuchlik,

. 2016 ; 8 (-) : 83. [pub] 20160420

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc16019933

Alzheimer's disease (AD) is one of the most serious human, medical, and socioeconomic burdens. Here we tested the hypothesis that a rat model of AD (Samaritan; Taconic Pharmaceuticals, USA) based on the application of amyloid beta42 (Abeta42) and the pro-oxidative substances ferrous sulfate heptahydrate and L-buthionine-(S, R)-sulfoximine, will exhibit cognitive deficits and disruption of the glutamatergic and cholinergic systems in the brain. Behavioral methods included the Morris water maze (MWM; long-term memory version) and the active allothetic place avoidance (AAPA) task (acquisition and reversal), testing spatial memory and different aspects of hippocampal function. Neurochemical methods included testing of the NR1/NR2A/NR2B subunits of NMDA receptors in the frontal cortex and CHT1 transporters in the hippocampus, in both cases in the right and left hemisphere separately. Our results show that Samaritan rats(™) exhibit marked impairment in both the MWM and active place avoidance tasks, suggesting a deficit of spatial learning and memory. Moreover, Samaritan rats exhibited significant changes in NR2A expression and CHT1 activity compared to controls rats, mimicking the situation in patients with early stage AD. Taken together, our results corroborate the hypothesis that Samaritan rats are a promising model of AD in its early stages.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16019933
003      
CZ-PrNML
005      
20160727105907.0
007      
ta
008      
160722s2016 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnagi.2016.00083 $2 doi
024    7_
$a 10.3389/fnagi.2016.00083 $2 doi
035    __
$a (PubMed)27148049
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Petrasek, Tomas $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of SciencesPrague, Czech Republic; National Institute of Mental HealthKlecany, Czech Republic.
245    12
$a A Rat Model of Alzheimer's Disease Based on Abeta42 and Pro-oxidative Substances Exhibits Cognitive Deficit and Alterations in Glutamatergic and Cholinergic Neurotransmitter Systems / $c T. Petrasek, M. Skurlova, K. Maleninska, I. Vojtechova, Z. Kristofikova, H. Matuskova, J. Sirova, K. Vales, D. Ripova, A. Stuchlik,
520    9_
$a Alzheimer's disease (AD) is one of the most serious human, medical, and socioeconomic burdens. Here we tested the hypothesis that a rat model of AD (Samaritan; Taconic Pharmaceuticals, USA) based on the application of amyloid beta42 (Abeta42) and the pro-oxidative substances ferrous sulfate heptahydrate and L-buthionine-(S, R)-sulfoximine, will exhibit cognitive deficits and disruption of the glutamatergic and cholinergic systems in the brain. Behavioral methods included the Morris water maze (MWM; long-term memory version) and the active allothetic place avoidance (AAPA) task (acquisition and reversal), testing spatial memory and different aspects of hippocampal function. Neurochemical methods included testing of the NR1/NR2A/NR2B subunits of NMDA receptors in the frontal cortex and CHT1 transporters in the hippocampus, in both cases in the right and left hemisphere separately. Our results show that Samaritan rats(™) exhibit marked impairment in both the MWM and active place avoidance tasks, suggesting a deficit of spatial learning and memory. Moreover, Samaritan rats exhibited significant changes in NR2A expression and CHT1 activity compared to controls rats, mimicking the situation in patients with early stage AD. Taken together, our results corroborate the hypothesis that Samaritan rats are a promising model of AD in its early stages.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skurlova, Martina $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
700    1_
$a Maleninska, Kristyna $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
700    1_
$a Vojtechova, Iveta $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
700    1_
$a Kristofikova, Zdena $u National Institute of Mental Health Klecany, Czech Republic.
700    1_
$a Matuskova, Hana $u National Institute of Mental Health Klecany, Czech Republic.
700    1_
$a Sirova, Jana $u National Institute of Mental Health Klecany, Czech Republic.
700    1_
$a Vales, Karel $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
700    1_
$a Ripova, Daniela $u National Institute of Mental Health Klecany, Czech Republic.
700    1_
$a Stuchlik, Ales $u Department of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences Prague, Czech Republic.
773    0_
$w MED00174539 $t Frontiers in aging neuroscience $x 1663-4365 $g Roč. 8, č. - (2016), s. 83
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27148049 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160727110128 $b ABA008
999    __
$a ind $b bmc $g 1154603 $s 944461
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 8 $c - $d 83 $e 20160420 $i 1663-4365 $m Frontiers in aging neuroscience $n Front Aging Neurosci $x MED00174539
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Možnosti archivace